In case you missed it, Ike Brannon, health care economist and senior fellow at the Jack Kemp Foundation, published a new white paper, “Recently Proposed Federal and State Legislation To Constrain Pharmacy Benefit Managers Would Not Reduce Drug Costs,” in
Proponents of policies targeting pharmacy benefit companies ignore the costly repercussions of undermining pharmacy benefit managers’ (PBMs) ability to secure savings that enable health plan sponsors to offer quality, affordable prescription drug benefits. Proposals being pushed to “lower drug costs” that
POSITION SUMMARY Position Senior Director or Assistant Vice President, Regulatory Affairs Organization Pharmaceutical Care Management Association (PCMA) Location Washington, D.C. Reporting Relationship Reports to the Senior Vice President, Policy & Regulatory Insights Website www.pcmanet.org ORGANIZATION The Pharmaceutical Care Management
POSITION SUMMARY Position Senior Manager or Director, Policy Organization Pharmaceutical Care Management Association (PCMA) Location Washington, D.C. Reporting Relationship Reports to the Vice President, Policy Website www.pcmanet.org ORGANIZATION The Pharmaceutical Care Management Association (PCMA) is the national association representing America’s
Position Senior Director, Federal Affairs Organization Pharmaceutical Care Management Association (PCMA) Location Washington, D.C. Reporting Relationship Reports to the Senior Vice President, Federal & Political Affairs Website www.pcmanet.org ORGANIZATION The Pharmaceutical Care Management Association (PCMA) is the national association representing
Prohibiting employers and health plan sponsors from choosing how they compensate pharmacy benefit companies (PBMs) based on the savings they provide (also termed “delinking”) will encourage drug manufacturers to raise their prices.
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on the Administration’s listening session on PBMs. “Today’s White House listening session on PBMs, where policymakers only hear from people and groups with vocal anti-PBM agendas, will
Research Advocacy Documents External Resources
Research Advocacy Documents External Resources
©2024 PCMA. All Rights Reserved.
